Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Series A Preferred Stock [Member]	Series B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Parent [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, amount at Dec. 31, 2019			$ 10,001	$ 56,772,175	$ 1,458,289	$ (42,089,625)	$ 16,150,839	$ 7,067,596	$ 23,218,435
Beginning balance, shares at Dec. 31, 2019			10,001,000
Subsidiary’s Issuance of Stock				2,025,807			2,025,807	353,537	2,379,344
Proceeds from Selling Subsidiary Equity				3,270			3,270	1,730	5,000
Change in Unrealized Loss on Investment					(8,240)		(8,240)	(4,359)	(12,599)
Foreign Currency Translations					(1,094,810)		(1,094,810)	(579,211)	(1,674,021)
Distribution to Non-Controlling Shareholders								(197,400)	(197,400)
Net Income (Loss)						1,615,002	1,615,002	636,439	2,251,441
Ending balance, amount at Mar. 31, 2020			$ 10,001	58,801,252	355,239	(40,474,623)	18,691,868	7,278,332	25,970,200
Ending balance, shares at Mar. 31, 2020			10,001,000
Beginning balance, amount at Dec. 31, 2019			$ 10,001	56,772,175	1,458,289	(42,089,625)	16,150,839	7,067,596	23,218,435
Beginning balance, shares at Dec. 31, 2019			10,001,000
Net Income (Loss)									(183,073)
Ending balance, amount at Jun. 30, 2020			$ 6,400	59,638,866	734,482	(41,639,677)	18,740,070	7,496,049	26,236,119
Ending balance, shares at Jun. 30, 2020			6,400,000
Beginning balance, amount at Mar. 31, 2020			$ 10,001	58,801,252	355,239	(40,474,623)	18,691,868	7,278,332	25,970,200
Beginning balance, shares at Mar. 31, 2020			10,001,000
Cancellation of Outstanding Stock			$ (3,601)	3,601
Cancellation of Outstanding Stock, shares			(3,601,000)
Change in Minority Interest				(445,936)	(18,317)		(464,253)	464,253
Subsidiary’s Issuance of Stock				1,262,990			1,262,990	770,156	2,033,146
Proceeds from Selling Subsidiary Equity				16,959			16,959	10,341	27,300
Change in Unrealized Loss on Investment					8,147		8,147	4,968	13,115
Foreign Currency Translations					389,413		389,413	237,459	626,872
Net Income (Loss)						(1,165,054)	(1,165,054)	(1,269,460)	(2,434,514)
Ending balance, amount at Jun. 30, 2020			$ 6,400	59,638,866	734,482	(41,639,677)	18,740,070	7,496,049	26,236,119
Ending balance, shares at Jun. 30, 2020			6,400,000
Beginning balance, amount at Dec. 31, 2020			$ 8,570	102,729,944	2,143,338	(44,910,297)	59,971,555	38,023,260	97,994,815
Beginning balance, shares at Dec. 31, 2020			8,570,000
Issuance of Stock for Services			$ 10	60,890			60,900		60,900
Issuance of Stock for Services, shares			10,000
Transactions under Common Control				(57,190,499)			(57,190,499)		(57,190,499)
Sale of Vivacitas to Related Party				2,279,872			2,279,872		2,279,872
Purchase Stock of True Partner from Related Party				3,274,060			3,274,060		3,274,060
Beneficial Conversion Feature Intrinsic Value, Net				50,770,192			50,770,192		50,770,192
Subsidiary’s Issuance of Stock				46,099			46,099	34,677	80,776
Proceeds from Selling Subsidiary Equity				142,675			142,675	107,325	250,000
Change in Non-Controlling Interest				76,412	(39,067)		37,345	(37,345)
Change in Unrealized Loss on Investment					(1,135)		(1,135)	(852)	(1,987)
Foreign Currency Translations					(1,010,527)		(1,010,527)	(758,913)	(1,769,440)
Distribution to Non-Controlling Shareholders								(82,250)	(82,250)
Net Income (Loss)						(6,238,449)	(6,238,449)	(3,569,112)	(9,807,561)
Ending balance, amount at Mar. 31, 2021			$ 8,580	102,189,645	1,092,609	(51,148,746)	52,142,088	33,716,790	85,858,878
Ending balance, shares at Mar. 31, 2021			8,580,000
Beginning balance, amount at Dec. 31, 2020			$ 8,570	102,729,944	2,143,338	(44,910,297)	59,971,555	38,023,260	97,994,815
Beginning balance, shares at Dec. 31, 2020			8,570,000
Net Income (Loss)									(84,696,885)
Ending balance, amount at Jun. 30, 2021			$ 28,265	204,762,770	(40,823)	(117,799,610)	86,950,602	28,114,184	115,064,786
Ending balance, shares at Jun. 30, 2021			28,265,289
Beginning balance, amount at Mar. 31, 2021			$ 8,580	102,189,645	1,092,609	(51,148,746)	52,142,088	33,716,790	85,858,878
Beginning balance, shares at Mar. 31, 2021			8,580,000
Issuance of Common Stock			$ 8,389	39,260,191			39,268,580		39,268,580
Issuance of Common Stock, shares			8,389,324
Convert Common stock to Series A Preferred Stock	$ 6		$ (6,380)	6,374
Change Common stock to Series A Preferred Stock, shares	6,380		(6,380,000)
Convert Related Party Note Payable to Series B Preferred Stock		2		12,999,998			13,000,000		13,000,000
Issuance of Series B Prefered Stock, shares	2,132
Convert Series A and B Preferred Stock to Common Stock	$ (6)	$ (2)	$ 8,512	(8,504)
Convert Preferred Stock Series A and B to Common, shares	(6,380)	(2,132)	8,512,000
Convert Related Party Note Payable to Common Stock			$ 9,164	51,217,402			51,226,566		51,226,566
Convertible Note to Stock, shares			9,163,965
Subsidiary’s Issuance of Stock				1,961,349			1,961,349	784,100	2,745,449
Proceeds from Selling Subsidiary Equity				21,432			21,432	8,568	30,000
Change in Non-Controlling Interest				(2,885,117)	(343,225)		(3,228,342)	3,228,342
Change in Unrealized Loss on Investment					(25,663)		(25,663)	(10,259)	(35,922)
Foreign Currency Translations					(764,544)		(764,544)	(305,647)	(1,070,191)
Distribution to Non-Controlling Shareholders								(1,069,250)	(1,069,250)
Net Income (Loss)						(66,650,864)	(66,650,864)	(8,238,460)	(74,889,324)
Ending balance, amount at Jun. 30, 2021			$ 28,265	$ 204,762,770	$ (40,823)	$ (117,799,610)	$ 86,950,602	$ 28,114,184	$ 115,064,786
Ending balance, shares at Jun. 30, 2021			28,265,289